These findings of increased [18F]-AV1451 SUVr binding are indicative cerebral tau pathology [40] also manifesting in AD patients along with increased CSF levels of tau and ptau along with reduced CSF-Aβ [58]. The gene discussed is MAPT; the disease is Alzheimer disease.